Bristol-Myers offloads manufacturing plant to Catalent
Catalent buys Italian manufacturing and packaging plant from Bristol-Myers Squibb, adding oral solid, biologics and sterile product capacity.
Catalent buys Italian manufacturing and packaging plant from Bristol-Myers Squibb, adding oral solid, biologics and sterile product capacity.
In terms of data generation, equipment currently used in bioprocessing is ‘pretty dumb’ and needs to become more sophisticated, explains Fujifilm CSO.